March 1, 2023 - Bayer

3/01/2023 – Covered Entity Letter

Can CE get 340B pricing if they share claims data?

Yes- 340B ESP

Are system owned contract pharmacies exempted from this policy?


Can CEs with no in-house pharmacy designate a contract pharmacy for 340B pricing access?


Drugs affected by this policy:

Adempas, Aliqopa, Jivi, Kerendia, Kogenate, Kovaltry, Kyleena, Lampit, Mirena, Skyla, Nubeqa, Xofigo

Policy applies to what entity types?

Policy applies to hospitals covered entities only. Federal grantees are exempted from this policy.